1st Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for XOMA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Veterans Affairs, Dept of (VA); Defense, Dept of (DOD)

Science/Technology SCI

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: Executive Office of the President (EOP); SENATE; Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Disaster Planning/Emergencies DIS

Biotechnology, Tax, Disaster Palnning, Homeland Security, Science and Technology and Pharmacy issues within the US House and US Senate.

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Defense, Dept of (DOD)

Health Issues HCR

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); SENATE; Defense, Dept of (DOD)

Homeland Security HOM

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate

LobbyistCovered position, as disclosed
DAVID AIMONE —
MARK LENKER —
BETHANY NOBLE —
PAUL S QUINN —

Contacted: Veterans Affairs, Dept of (VA); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.